Mapp Biopharmaceutical Revenue and Competitors
Estimated Revenue & Valuation
- Mapp Biopharmaceutical's estimated annual revenue is currently $12.1M per year.
- Mapp Biopharmaceutical's estimated revenue per employee is $155,000
Employee Data
- Mapp Biopharmaceutical has 78 Employees.
- Mapp Biopharmaceutical grew their employee count by 3% last year.
Mapp Biopharmaceutical's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP, Sudan Development | Reveal Email/Phone |
3 | VP Quality Control and Analytical Development | Reveal Email/Phone |
4 | VP, Product Development | Reveal Email/Phone |
5 | Senior Director, Head Nonclinical Development | Reveal Email/Phone |
6 | Director, Nonclinical Development | Reveal Email/Phone |
7 | Director Regulatory Affairs | Reveal Email/Phone |
8 | Director, Analytical Development | Reveal Email/Phone |
9 | Director, CMC Project Management | Reveal Email/Phone |
10 | Director Science | Reveal Email/Phone |
Mapp Biopharmaceutical Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Mapp Biopharmaceutical?
Mapp Biopharmaceutical Inc is a Biotechnology company located in 6160 Lusk Blvd Ste C105, San Diego, California, United States.
keywords:N/A
N/A
Total Funding
78
Number of Employees
$12.1M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Mapp Biopharmaceutical News
Mapp Biopharmaceutical, Serepata Therapeutics, Tekmira Pharmaceuticals, NewLink Genetics Corp., BioCryst Pharmaceutical Inc.
He co-founded Mapp Biopharmaceutical and ZabBio, and serves as President for both companies. His career focus has been on the development of...
“We are hopeful that the Orphan Medicinal Product designation from the EMA will ultimately result in access to ZMapp for those who need it,” CEO Kevin Whaley said in a statement. Promoted Telemedicine’s potential to provide healthcare to the world’s most vulnerable Teladoc Health Head of R&D ...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $9.6M | 78 | -5% | N/A |
#2 | $7.5M | 78 | 42% | N/A |
#3 | $15M | 78 | -26% | $43.2M |
#4 | $19.1M | 78 | 5% | N/A |
#5 | $12.5M | 78 | 10% | N/A |